» Articles » PMID: 24589483

Sulfur Rich 2-mercaptobenzothiazole and 1,2,3-triazole Conjugates As Novel Antitubercular Agents

Overview
Journal Eur J Med Chem
Specialty Chemistry
Date 2014 Mar 5
PMID 24589483
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

A series of benzfused heterocyclic derivatives such as amide conjugates of 2-(benzo[d]thiazol-2-ylthio)acetic acid with aromatic/aliphatic/cyclic secondary amines (5a-5o & 8a-8m); 1,2,3-triazole conjugates of 2-mercaptobenzothiazoles and amide conjugates of indole-3-glyoxalic acid with cyclic secondary amines (14a-14g) have been synthesized and were screened for their antitubercular activity against Mycobacterium tuberculosis H37Rv strain by broth microdilution assay method. Compounds 8b, 8f, 8g and 8l inhibited the growth of the H37Rv strain at concentrations of 8 μg/mL. These compounds (8b, 8f, 8g and 8l) have been further identified as bactericidal and are completely killing the microbes at 32-64 μg/mL concentrations. Molecular docking studies of the active compounds reveal that these compounds are targeting DprE1 and may act as DprE1 inhibitors.

Citing Articles

Novel hybrids of 1,2,3-triazole-benzoxazole: design, synthesis, and assessment of DprE1 enzyme inhibitors using fluorometric assay and computational analysis.

Singh M, Batt S, Canales C, Pavan F, Arun Kumar S, Akshatha H J Enzyme Inhib Med Chem. 2024; 39(1):2403744.

PMID: 39329328 PMC: 11441021. DOI: 10.1080/14756366.2024.2403744.


Antitubercular activity of 2-mercaptobenzothiazole derivatives targeting type II NADH dehydrogenase.

Saha P, Sau S, Kalia N, Sharma D RSC Med Chem. 2024; 15(5):1664-1674.

PMID: 38784457 PMC: 11110738. DOI: 10.1039/d4md00118d.


Study on the Antifungal Activity of Gallic Acid and Its Azole Derivatives against .

Zheng Y, Geng Y, Hou W, Li Z, Cheng C, Wang X Molecules. 2024; 29(9).

PMID: 38731487 PMC: 11085095. DOI: 10.3390/molecules29091996.


Copper-Catalyzed Azide-Alkyne Cycloaddition-Oriented Multifunctional Bio-Orthogonal Linker BPPA: Design, Synthesis and Evaluation.

Wang S, He X, Li J, Shi E Molecules. 2023; 28(24).

PMID: 38138573 PMC: 10745683. DOI: 10.3390/molecules28248083.


Ligand-based pharmacophore modelling, structure optimisation, and biological evaluation for the identification of 2-heteroarylthio--arylacetamides as novel HSP90 C-terminal inhibitors.

Liu Y, Li C, Li Y, Zhang S, Zhang N, Bian X J Enzyme Inhib Med Chem. 2023; 39(1):2290912.

PMID: 38083866 PMC: 11721760. DOI: 10.1080/14756366.2023.2290912.